These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9059472)

  • 21. Clinical physiological data on the bronchodilator effect of Duovent versus salbutamol in chronic obstructive lung disease.
    Marangio E; Pesci A; Mori A; Marchioni M; Bertorelli G
    Respiration; 1986; 50 Suppl 2():165-8. PubMed ID: 2951798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of acute bronchodilator effects of inhaled ipratropium bromide and salbutamol in bronchial asthma.
    Chhabra SK; Pandey KK
    J Asthma; 2002 Aug; 39(5):375-81. PubMed ID: 12214891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD.
    Oga T; Nishimura K; Tsukino M; Sato S; Hajiro T; Mishima M
    Chest; 2003 Jun; 123(6):1810-6. PubMed ID: 12796154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
    Georgopoulos D; Wong D; Anthonisen NR
    Chest; 1990 Feb; 97(2):280-4. PubMed ID: 1967572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease.
    Paggiaro PL; Vagaggini B; Di Franco A; Zingoni M; Fano M; Biraghi M
    Respiration; 2006; 73(5):603-9. PubMed ID: 16293958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
    Singh D; Abbott-Banner K; Bengtsson T; Newman K
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is oral theophylline effective in combination with both inhaled anticholinergic agent and inhaled beta 2-agonist in the treatment of stable COPD?
    Nishimura K; Koyama H; Ikeda A; Izumi T
    Chest; 1993 Jul; 104(1):179-84. PubMed ID: 8325065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute effects of nebulized salbutamol on resting energy expenditure in patients with chronic obstructive pulmonary disease and in healthy subjects.
    Creutzberg EC; Schols AM; Bothmer-Quaedvlieg FC; Wesseling G; Wouters EF
    Respiration; 1998; 65(5):375-80. PubMed ID: 9782220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salbutamol and ipratropium in partially reversible airway obstruction.
    Connolly CK; Chan NS
    Br J Dis Chest; 1987 Jan; 81(1):55-61. PubMed ID: 2959307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
    Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
    Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD].
    Ozdemir T; Geçkin E; Oğüş C; Cilli A
    Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
    Dai L; Li X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of theophylline on metabolic rate in chronic obstructive lung disease patients.
    Mosier K; Renvall MJ; Ramsdell JW; Spindler AA
    J Am Coll Nutr; 1996 Aug; 15(4):403-7. PubMed ID: 8829097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
    Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
    Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does a single dose of the phosphodiesterase 4 inhibitor, cilomilast (15 mg), induce bronchodilation in patients with chronic obstructive pulmonary disease?
    Grootendorst DC; Gauw SA; Baan R; Kelly J; Murdoch RD; Sterk PJ; Rabe KF
    Pulm Pharmacol Ther; 2003; 16(2):115-20. PubMed ID: 12670781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
    Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
    Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma.
    Hossain AS; Barua UK; Roy GC; Sutradhar SR; Rahman I; Rahman G
    Mymensingh Med J; 2013 Apr; 22(2):345-52. PubMed ID: 23715360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
    O'Driscoll BR; Taylor RJ; Horsley MG; Chambers DK; Bernstein A
    Lancet; 1989 Jun; 1(8652):1418-20. PubMed ID: 2567431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.